v3.26.1
Basis of Presentation and Significant Accounting Policies - Schedule of Revenue Consist of Product Sales to Customers (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Disaggregation of Revenue [Line Items]        
Total revenues $ 307,959 $ 264,566 $ 576,021 $ 508,882
NUPLAZID        
Disaggregation of Revenue [Line Items]        
Total revenues 183,132 168,479 350,056 328,199
DAYBUE products        
Disaggregation of Revenue [Line Items]        
Total revenues $ 124,827 $ 96,087 $ 225,965 $ 180,683